NCT02426814

Brief Summary

The purpose of this study is to assess the use of a mobile health intervention to improve adherence to asthma medication among adolescents. The intervention consists of an inhaler sensor strap to monitor asthma inhaler use and a mobile phone application to remind and incentivize patients to use their medication. This study will assess medication use throughout a 12 week study in patients who receive a mobile app with reminders, asthma control as measured by the ACT \[asthma control test\], and lung function as measured by spirometry.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 27, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

7.9 years

First QC Date

April 7, 2015

Last Update Submit

July 24, 2023

Conditions

Keywords

Patient ComplianceMobile Applications

Outcome Measures

Primary Outcomes (1)

  • Real-time medication adherence in patients using mobile app compared to standard care.

    Analysis of real-time medication use data in the experimental \[app + sensor\] arm vs the sensor only arm.

    12 weeks

Secondary Outcomes (2)

  • Asthma control in patients using mobile app compared to standard care

    12 weeks

  • Change in lung function with use of a mobile health tool for asthma adherence

    12 weeks

Study Arms (2)

Standard Care with Medication Monitoring

SHAM COMPARATOR

Patients will be given an inhaler sensor to monitor medication use and a sham version of the mobile app that will not include reminders or incentives. Intervention: inhaler sensor

Device: Inhaler sensor

Medication Monitoring and Mobile App

EXPERIMENTAL

Patients will be given an inhaler sensor to monitor medication use and a mobile phone application with reminders to allow self-management of medication use. Interventions: inhaler sensor and mobile application for asthma adherence

Device: Inhaler sensorBehavioral: Mobile application for asthma adherence

Interventions

Inhaler sensor strap that tracks inhaler use.

Medication Monitoring and Mobile AppStandard Care with Medication Monitoring

Mobile phone application that sends reminders and allows patients to self-manage their medication adherence.

Medication Monitoring and Mobile App

Eligibility Criteria

Age11 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 11-19
  • Asthma diagnosis
  • Currently prescribed a hydrofluoroalkane (HFA) asthma controller medication
  • English-speaking
  • Has a smartphone or access to a smartphone or tablet

You may not qualify if:

  • Pregnant
  • Foster Care
  • Emancipated minor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

AsthmaPatient Compliance

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Andrew Ting, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Michael Parides, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2015

First Posted

April 27, 2015

Study Start

August 1, 2015

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations